​

AbCellera Biologics Ownership | Who Owns AbCellera Biologics?


OverviewForecastRevenueFinancialsChartTranscripts

AbCellera Biologics Ownership Summary


AbCellera Biologics is owned by 39.70% institutional investors, 21.49% insiders, and 38.82% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 10.14% of ABCL shares. American Funds SMALLCAP World A is the top mutual fund, with 4.08% of its assets in AbCellera Biologics shares.

ABCL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAbCellera Biologics39.70%21.49%38.82%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustryBiotech Stocks 181.71%11.69%-93.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp30.28M10.14%$105.66M
Capital world investors13.58M4.44%$198.12M
Two sigma investments, lp10.56M3.54%$36.86M
Td waterhouse canada9.56M3.20%$33.57M
Marshall wace, llp8.96M2.93%$130.70M
Ubs asset management americas7.58M2.54%$26.44M
Blackrock funding, inc. /de5.66M1.85%$82.59M
Two sigma advisers, lp4.80M1.61%$24.14M
Arrowmark colorado4.11M1.37%$14.33M
Driehaus capital management4.02M1.35%$14.05M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Intellectus partners584.13K1.42%$8.52M
Guardian partners1.79M0.90%$10.65B
Baker bros. advisors lp30.28M0.61%$105.66M
Guardian capital advisors lp1.79M0.53%$5.00M
Tang capital management2.60M0.50%$13.08M
Arrowmark colorado4.11M0.38%$14.33M
Neo ivy capital management118.19K0.38%$1.72M
Brandywine managers28.49K0.20%$415.64K
Virtus investment advisers60.56K0.20%$883.57K
Networth advisors22.53K0.19%$328.65K

Top Buyers

HolderShares% AssetsChange
Td waterhouse canada9.56M0.10%9.54M
Marshall wace, llp8.96M0.11%7.06M
Two sigma investments, lp10.56M0.03%4.75M
Baker bros. advisors lp30.28M0.61%2.75M
Jefferies financial group2.75M0.07%2.75M

Top Sellers

HolderShares% AssetsChange
Baillie gifford---10.42M
Founders fund vii management---3.77M
Orbimed advisors---3.34M
Prosight management, lp---2.82M
Casdin capital---2.36M

New Positions

HolderShares% AssetsChangeValue
Jefferies financial group2.75M0.07%2.75M$9.58M
Alyeska investment group2.59M0.03%2.59M$9.05M
Franklin resources1.54M0.00%1.54M$18.91M
Pictet asset management sa275.90K0.00%275.90K$4.09M
Voya investment management188.01K0.00%188.01K$2.74M

Sold Out

HolderChange
Clearstead advisors-26.00
Gamma investing-46.00
Morton brown family wealth-75.00
Atticus wealth management-100.00
Gill capital partners-100.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20261722.38%121,292,2344.46%392.75%9217.95%50-5.66%
Jun 30, 20261679.87%116,099,374-6.58%372.26%771.32%5360.61%
Mar 31, 2026123-20.65%57,774,841-46.71%191.47%63-19.23%22-47.62%
Dec 31, 202533-78.71%3,299,502-96.83%10.09%12-85.19%12-67.57%
Sep 30, 202553-60.15%12,673,344-88.22%40.32%24-57.89%17-61.36%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A13.23M4.08%-
Allianz Global Artfcl Intlgc W EUR6.17M2.07%-7.81K
UBS (Lux) Digital Health Equity SB USD4.50M1.51%-
SMDS Global AI Equity Mother4.49M1.50%-
Baillie Gifford Positive Change3.89M1.30%-143.60K
Baillie Gifford Positive Change B Acc3.89M1.30%-128.37K
American Funds IS® Asset Allocation 12.87M0.97%-
Baillie Gifford WW Pstv Chg B USD Acc2.26M0.76%-72.26K
iShares Biotechnology ETF1.93M0.60%-12.48K
ACATIS Datini Valueflex Fonds A1.86M0.57%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 13, 2026Booth Andrew Chief Financial OfficerBuy$97.44K
Nov 12, 2026Thermopylae Holdings Ltd.-Buy$698.92K
Aug 24, 2026Hayden Michael R-Buy$570.44K
Aug 18, 2026Montalbano John S.-Buy$110.30K
Aug 14, 2026Booth Andrew Chief Financial OfficerBuy$383.90K

Insider Transactions Trends


DateBuySell
2026 Q42-
2026 Q34-
2026 Q21-
2026 Q13-
2025 Q41-

ABCL Ownership FAQ


Who Owns AbCellera Biologics?

AbCellera Biologics shareholders are primarily institutional investors at 39.70%, followed by 21.49% insiders and 38.81% retail investors. The average institutional ownership in AbCellera Biologics's industry, Biotech Stocks , is 181.71%, which AbCellera Biologics falls below.

Who owns the most shares of AbCellera Biologics?

AbCellera Biologics’s largest shareholders are Baker bros. advisors lp (30.28M shares, 10.14%), Capital world investors (13.58M shares, 4.44%), and Two sigma investments, lp (10.56M shares, 3.54%). Together, they hold 18.12% of AbCellera Biologics’s total shares outstanding.

Does Blackrock own AbCellera Biologics?

BlackRock is not among the top 10 institutional shareholders of AbCellera Biologics.

Who is AbCellera Biologics’s biggest shareholder by percentage of total assets invested?

Intellectus partners is AbCellera Biologics’s biggest shareholder by percentage of total assets invested, with 1.42% of its assets in 584.13K AbCellera Biologics shares, valued at 8.52M$.

Who is the top mutual fund holder of AbCellera Biologics shares?

American Funds SMALLCAP World A is the top mutual fund holder of AbCellera Biologics shares, with 4.08% of its total shares outstanding invested in 13.23M AbCellera Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools